Dr. Labiento Smith controls early myopia progression with low-dose Atropine and/or Orthokeratology. She bases her treatment on the current literature and recent LAMP study. These treatments for myopia control are considered an off-label use in the United States.. The medication Atropine and Ortho-K are FDA approved but under a different category and use. All children with active myopia progression at Sudbury Eye Care are seen bi-annually for exams to monitor progression.
I have received care Dr. Labiento-Smith since 2012 when I first moved to Sudbury. My wife and I have received great care. I ultimately got ICL surgery from Dr. Hu and was also very satisfied with his care. We now plan to take our daughters to Dr. Labiento-Smith as we have received such great care.
Patrick M. — Yelp